Published in Antimicrob Agents Chemother on March 01, 1994
Cefepime: a reappraisal in an era of increasing antimicrobial resistance. Expert Rev Anti Infect Ther (2008) 1.09
Uptake of cefepime by phagocytosing polymorphonuclear neutrophils and subsequent intracellular killing. Antimicrob Agents Chemother (1996) 0.95
Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients. Antimicrob Agents Chemother (1997) 0.84
Epidemiological and clinical features for cefepime heteroresistant Escherichia coli infections in Southwest China. Eur J Clin Microbiol Infect Dis (2016) 0.77
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
CDC definitions for nosocomial infections, 1988. Am J Infect Control (1988) 27.03
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1989) 3.41
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother (1985) 2.87
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother (1985) 2.48
A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med (1986) 2.26
beta-Lactamases and beta-lactam resistance in Escherichia coli. Antimicrob Agents Chemother (1985) 2.09
Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy. Antimicrob Agents Chemother (1986) 1.95
New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother (1985) 1.66
In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents. Antimicrob Agents Chemother (1985) 1.49
In vitro studies of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother (1985) 1.45
In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin. Antimicrob Agents Chemother (1985) 1.36
Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci. Antimicrob Agents Chemother (1985) 1.25
The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin. J Antimicrob Chemother (1986) 1.15
HR 810 and BMY-28142, two new cephalosporins with broad-spectrum activity: an in-vitro comparison with other beta-lactam antibiotics. J Antimicrob Chemother (1985) 1.10
Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections. Lancet (1988) 1.04
Ceftazidime therapy of serious bacterial infections. Antimicrob Agents Chemother (1983) 1.03
Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial. Ann Intern Med (1984) 1.02
Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients. Rev Infect Dis (1985) 0.89
Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides. Am J Med (1986) 0.89
Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound, and complicated urinary tract infections in hospitalized subjects. Antimicrob Agents Chemother (1991) 0.83
Open trial of cefepime (BMY 28142) for infections in hospitalized patients. Antimicrob Agents Chemother (1990) 0.82
International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections. J Antimicrob Chemother (1993) 0.81
Cephalosporin antimicrobial agents and related compounds. Mayo Clin Proc (1991) 0.78
Pefloxacin versus ceftazidime in the treatment of a variety of gram-negative-bacterial infections. Antimicrob Agents Chemother (1989) 0.78
Low-dosage cefepime as treatment for serious bacterial infections. J Antimicrob Chemother (1993) 0.78
Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care (2000) 3.75
Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol (1999) 3.56
Development and clinical evaluation of a polymerase chain reaction test for detection of Chlamydia trachomatis. J Clin Microbiol (1992) 3.01
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Ann Intern Med (1995) 1.93
Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections. J Infect Dis (1981) 1.83
Comparison of the autoSCAN-W/A and Vitek Automicrobic systems for identification and susceptibility testing of bacteria. Eur J Clin Microbiol Infect Dis (1992) 1.63
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann Intern Med (1987) 1.63
Bacterial flora in patients presenting with sore throat in Dutch general practice. Fam Pract (1993) 1.62
Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. J Infect Dis (1985) 1.45
[Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment]. Ned Tijdschr Geneeskd (1997) 1.44
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol (1997) 1.43
Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone. Antimicrob Agents Chemother (1991) 1.42
[Alcohol and coronary disease]. Ned Tijdschr Geneeskd (1996) 1.40
Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care (2000) 1.34
The sepsis syndrome in a Dutch university hospital. Clinical observations. Arch Intern Med (1993) 1.33
Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. Ann Intern Med (1981) 1.29
A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis. J Antimicrob Chemother (1990) 1.24
Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care (1997) 1.18
Detection of antigen in sera of patients with invasive aspergillosis: intra- and interlaboratory reproducibility. The Dutch Interuniversity Working Party for Invasive Mycoses. J Clin Microbiol (1998) 1.13
Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea. Eur J Clin Microbiol Infect Dis (1989) 1.12
Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med (2001) 1.11
Functional relationships in the nephrotic syndrome. Kidney Int (1984) 1.10
Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest (2000) 1.09
Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant (2000) 1.09
Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface. Antimicrob Agents Chemother (1990) 1.05
Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections. Lancet (1988) 1.04
Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy. Lancet (1999) 1.02
Effect of human polymorphonuclear and mononuclear leukocytes on chromosomal and plasmid DNA of Escherichia coli. Role of acid DNase. J Clin Invest (1984) 1.02
Allogeneic bone marrow transplantation can restore CD4+ T-lymphocyte count and immune function in idiopathic CD4+ T-lymphocytopenia. Bone Marrow Transplant (1996) 1.00
Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes. Infect Immun (1985) 1.00
[Fulminant sepsis caused by Streptococcus suis]. Ned Tijdschr Geneeskd (1990) 0.98
Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua. Int J Antimicrob Agents (2004) 0.97
Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. J Infect Dis (1998) 0.96
Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro. Eur J Clin Microbiol (1985) 0.95
Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS (2000) 0.95
Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis. Ann Rheum Dis (1991) 0.94
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance. Eur J Hum Genet (2001) 0.93
Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection. Scand J Infect Dis (1993) 0.93
Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus. Dutch AIDS Treatment Group. J Infect Dis (1995) 0.93
A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections. J Antimicrob Chemother (1993) 0.93
Pharmacokinetics of cefepime in patients with the sepsis syndrome. J Antimicrob Chemother (1993) 0.92
Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization. J Immunol (2001) 0.92
Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A (1993) 0.91
Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338). Eur J Clin Microbiol Infect Dis (1989) 0.91
Antibiotic sensitivity and synergism of 'penicillin-tolerant' Staphylococcus aureus. Chemotherapy (1979) 0.91
Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals. J Med Microbiol (1999) 0.91
Monoclonal antibodies specific for the phase-variant O-acetylated K1 capsule of Escherichia coli. J Clin Microbiol (1991) 0.91
Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli. J Med Microbiol (1986) 0.89
Plasma exchange in herpes gestationis. Br Med J (1980) 0.88
The influence of flucloxacillin and amoxicillin with clavulanic acid on the aerobic flora of the alimentary tract. Infection (1987) 0.88
Rothia dentocariosa endocarditis complicated by an abdominal aneurysm. Clin Infect Dis (1994) 0.88
Clinical expression of a rare beta-globin gene mutation co-inherited with haemoglobin E-disease. Eur J Clin Chem Clin Biochem (1996) 0.88
Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains. J Clin Microbiol (1993) 0.88
Pharmacokinetics of cefepime in patients with respiratory tract infections. Antimicrob Agents Chemother (1990) 0.88
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection. J Infect Dis (1994) 0.87
The biological half-life of I-131 fibrinogen. Thromb Diath Haemorrh Suppl (1965) 0.87
Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. J Infect Dis (2000) 0.87
Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. University of Zimbabwe Meningitis Group. J Infect Dis (1997) 0.87
Plasma and blood volumes in patients with the nephrotic syndrome. Nephron (1984) 0.86
A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome. Int J Antimicrob Agents (1997) 0.86
Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis. J Neuroimmunol (2000) 0.86
Morphine enhances complement receptor-mediated phagocytosis of Cryptococcus neoformans by human microglia. Clin Immunol Immunopathol (1998) 0.86
Is a second urine specimen necessary for the diagnosis of asymptomatic bacteriuria? Clin Infect Dis (2000) 0.84
Effect of cytokines on anticryptococcal activity of human microglial cells. Clin Diagn Lab Immunol (1998) 0.84
Issues in the adjunct therapy of severe sepsis. J Antimicrob Chemother (1996) 0.84
Lowered tissue-fluid oncotic pressure protects the blood volume in the nephrotic syndrome. Nephron (1986) 0.84
Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833) for treatment of complicated urinary tract infections. Antimicrob Agents Chemother (1990) 0.84
Comparative study of ceftriaxone monotherapy versus a combination regimen of cefuroxime plus gentamicin for treatment of serious bacterial infections: the efficacy, safety and effect on fecal flora. Chemotherapy (1988) 0.83
Leishmania braziliensis presenting as a granulomatous lesion of the nasal septum mucosa. J Laryngol Otol (1997) 0.83
Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT. Bone Marrow Transplant (1993) 0.83
Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes. Zentralbl Bakteriol (1991) 0.83
Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers. Eur J Clin Microbiol Infect Dis (2002) 0.82
Emergence and infectious complications of ciprofloxacin-resistant Escherichia coli in haematological cancer patients. Eur J Clin Microbiol Infect Dis (1998) 0.82
Spatial receptive fields of inferior colliculus neurons to auditory apparent motion in free field. J Neurophysiol (2001) 0.82
Disseminated Nocardia asteroides infection complicating renal transplantation. Neth J Med (1987) 0.82
Blood volume and sodium retention in the nephrotic syndrome: a controversial pathophysiological concept. Nephron (1984) 0.82
Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains. Drugs Exp Clin Res (1988) 0.82
Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis. Infection (1987) 0.82
Acute inhibitory effect of alcohol on fibrinolysis. Eur J Clin Invest (2001) 0.82
Congenital afibrinogenemia in goats. Zentralbl Veterinarmed A (1972) 0.81
A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants. Clin Infect Dis (1997) 0.81
Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria. Infection (1983) 0.81
Deficient antipneumococcal polysaccharide responses in HIV-seropositive patients. FEMS Immunol Med Microbiol (1995) 0.81
The role of alcohol in the anti low density lipoprotein oxidation activity of red wine. Atherosclerosis (1999) 0.81
A randomised, multicentre study of ceftriaxone versus standard therapy in the treatment of lower respiratory tract infections. Int J Antimicrob Agents (1999) 0.81
A case of disseminated infection with Pichia ohmeri. Eur J Clin Microbiol Infect Dis (2000) 0.81
Oerskovia xanthineolytica: a new pathogen in bone marrow transplantation. Bone Marrow Transplant (1998) 0.81
Virulence factors of Escherichia coli isolated from urine of diabetic women with asymptomatic bacteriuria: correlation with clinical characteristics. Antonie Van Leeuwenhoek (2001) 0.80
A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers. Am J Surg (1998) 0.80
Comparative in vitro antimicrobial activity of carumonam (Ro 17-2301) and its influence on the activity of other antibiotics. Chemotherapy (1987) 0.80
Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir. Bone Marrow Transplant (1989) 0.80
Lowered protein content of tissue fluid in patients with the nephrotic syndrome: observations during disease and recovery. Nephron (1985) 0.80
Use of an immunoglobulin M containing preparation for treatment of two hypogammaglobulinemic patients with persistent Campylobacter jejuni infection. Eur J Clin Microbiol Infect Dis (1993) 0.80
Monoclonal gammopathy (IgG) and chronic ulcerative dermatitis (phagedenic pyoderma). Acta Med Scand (1969) 0.80
Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria. J Infect Dis (1991) 0.80